AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Net Asset Value Dec 6, 2018

7665_sha_2018-12-06_1189e501-20f3-4bb3-837a-4c7fa14107d0.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6704J

Geiger Counter Ltd

06 December 2018

06 December 2018

GEIGER COUNTER LIMITED

(THE "COMPANY")

Issue of Ordinary Shares

The Company announces that, conditional only on Admission becoming effective, it has allotted, by way of a new issue in response to market demand, 425,000 new ordinary shares of no par value (the "New Shares") for cash, at a price of 22.5p per share, a premium to the Company's net asset value. The New Shares will rank pari passu with the existing ordinary shares.

Applications have been made for the New Shares to be admitted to The International Stock Exchange's Listing and to trading on the London Stock Exchange's SETSqx platform ("Admission"). Admission is expected to become effective, and dealings in the New Shares are expected to commence, at 8.00 a.m. on 11 December 2018.

Following the issue of the New Shares, the Company's issued share capital will consist of 82,977,880 ordinary shares and 37,483,835 subscription shares, none of which are held in treasury.

Enquiries

CQS (UK) LLP Craig Cleland T: +44 (0) 20 7201 5368
Cantor Fitzgerald Europe Robert Peel T: +44 (0) 20 7894 7719
R&H Fund Services (Jersey) Limited Jane De Barros-Sousa T :+44 (0) 1534 825 259

Important Information

The information contained in this announcement does not constitute an offer of securities for sale in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEFKADDKBDDNBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.